Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
- PMID: 7549059
Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
Abstract
Hepatitis B virus reinfection as well as recurrence of hepatocellular carcinoma are frequent complications in liver allograft recipients. This is the report of a patient who had two liver transplantations with a 6-year interval, both for the same indication-postnecrotic cirrhosis and liver cancer. Following first and second transplantation, hepatitis B reinfection occurred at 12 and 6 months, and allograft cirrhosis developed after 20 and 10 months, respectively. Intrahepatic recurrence of hepatocellular carcinoma was found after 69 months. Two years following retransplantation, the patient is tumor-free, and has normal graft function. In selected patients with hepatitis B-related liver disease, and hepatocellular carcinoma liver replacement is indicated when combined with effective immunoprophylaxis, and other adjuvant therapy. Late recurrence of both diseases is unusual, and retransplantation may come into question.
Similar articles
-
Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma.Am J Gastroenterol. 1995 Jan;90(1):29-34. Am J Gastroenterol. 1995. PMID: 7801944 Clinical Trial.
-
[Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].An Sist Sanit Navar. 2004;27 Suppl 2:91-101. An Sist Sanit Navar. 2004. PMID: 15381947 Review. Spanish.
-
[Recurrence of virus B hepatitis after liver transplantation].Gastroenterol Clin Biol. 1992;16(5):430-3. Gastroenterol Clin Biol. 1992. PMID: 1326456 French.
-
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.J Am Coll Surg. 1994 Apr;178(4):379-84. J Am Coll Surg. 1994. PMID: 8149037
-
Recurrence of diseases following orthotopic liver transplantation.Am J Gastroenterol. 2006 Jun;101(6):1370-8. doi: 10.1111/j.1572-0241.2006.00586.x. Am J Gastroenterol. 2006. PMID: 16771963 Review.
Cited by
-
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.World J Gastroenterol. 2015 Oct 21;21(39):11185-98. doi: 10.3748/wjg.v21.i39.11185. World J Gastroenterol. 2015. PMID: 26494973 Free PMC article.
-
Recurrence of hepatocellular carcinoma at the porta-hepatis following liver transplantation diagnosed on EUS-FNA.Clin J Gastroenterol. 2019 Aug;12(4):336-340. doi: 10.1007/s12328-019-00934-6. Epub 2019 Jan 17. Clin J Gastroenterol. 2019. PMID: 30656559
-
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.Ann Transplant. 2022 Apr 5;27:e935604. doi: 10.12659/AOT.935604. Ann Transplant. 2022. PMID: 35379768 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical